Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Clinical trial NCT05621837 · RECRUITING

Trial details

NCT number: NCT05621837
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: RECRUITING
Study type: OBSERVATIONAL

Melanoma Breast Cancer Renal Cell Carcinoma Urinary Bladder Cancer Squamous Cell Carcinoma of Head and Neck Small Cell Carcinoma NSCLC

Start date: 2022-03-10
Primary completion: 2026-12-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.